Blood Type B antigen modulates cell migration through regulating cdc42 expression and activity in HaCaT cells

Journal of Cellular Physiology

Volumn 228, Issue 11, 2013, Pages 2243-2251

  Jung, Ji Yong ^a,b,c   Oh, Jang Hee ^a,b,c   Lee, Dong Hun ^a,b,c   Lee, Serah ^a,b,c   Chung, Jin Ho ^a,b,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BLOOD GROUP ABH ANTIGEN; BLOOD GROUP B ANTIGEN; PROTEIN CDC42; SMALL INTERFERING RNA;

ACTIN POLYMERIZATION; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVITY; CELL MIGRATION; IN VITRO STUDY; KERATINOCYTE; LAMELLIPODIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES, NEUTRALIZING; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL MOVEMENT; COLLAGEN TYPE I; DOWN-REGULATION; FUCOSYLTRANSFERASES; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTEGRIN ALPHA2BETA1; KERATINOCYTES; PSEUDOPODIA; RNA, SMALL INTERFERING; TOUCH; TRANSCRIPTION, GENETIC; TRANSFECTION; WOUND HEALING;

EID: 84881252849     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24393     Document Type: Article

References (44)

1. Anstee DJ. 2010. The relationship between blood groups and disease. Blood 115:4635-4643.
2. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601.
3. Baum CL, Arpey CJ. 2005. Normal cutaneous wound healing: Clinical correlation with cellular and molecular events. Dermatol Surg 31:674-686; discussion 686.
4. Clausen H, Hakomori S. 1989. ABH and related histo-blood group antigens; Immunochemical differences in carrier isotypes and their distribution. Vox Sang 56:1-20.
5. Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A, Lawrence TS. 2008. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res 68:3803-3809.
6. Dabelsteen E, Gao S. 2005. ABO blood-group antigens in oral cancer. J Dent Res 84:21-28.
7. Dabelsteen E, Buschard K, Hakomori S, Young WW. 1984. Pattern of distribution of blood group antigens on human epidermal cells during maturation. J Invest Dermatol 82:13-17.
8. Defize LH, Arndt-Jovin DJ, Jovin TM, Boonstra J, Meisenhelder J, Hunter T, de Hey HT, de Laat SW. 1988. A431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover. J Cell Biol 107:939-949.
9. Dwek RA. 1996. Glycobiology: Toward understanding the function of sugars. Chem Rev 96:683-720.
10. Engelmann B, Schumacher U, Haen E. 1992. Epidermal growth factor binding sites on human erythrocytes in donors with different ABO blood groups. Am J Hematol 39:239-241.
11. Flores J, Okhuysen PC. 2009. Genetics of susceptibility to infection with enteric pathogens. Curr Opin Infect Dis 22:471-476.
12. Garrigues J, Anderson J, Hellstrom KE, Hellstrom I. 1994. Anti-tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes. J Cell Biol 125:129-142.
13. Greenwell P. 1997. Blood group antigens: Molecules seeking a function? Glycoconj J 14:159-173.
14. Gu J, Taniguchi N. 2004. Regulation of integrin functions by N-glycans. Glycoconj J 21:9-15.
15. Hakomori S. 1991. Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol 3:646-653.
16. Hakomori S. 1999. Antigen structure and genetic basis of histo-blood groups A, B and O: Their changes associated with human cancer. Biochim Biophys Acta 1473:247-266.
17. Ichikawa D, Handa K, Withers DA, Hakomori S. 1997. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: Approach with A and B gene transfection. Cancer Res 57:3092-3096.
18. Ichikawa D, Handa K, Hakomori S. 1998. Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int J Cancer 76:284-289.
19. Janik ME, Litynska A, Vereecken P. 2010. Cell migration-the role of integrin glycosylation. Biochim Biophys Acta 1800:545-555.
20. Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J. 1994. H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54:6275-6281.
21. Lauffenburger DA, Horwitz AF. 1996. Cell migration: A physically integrated molecular process. Cell 84:359-369.
22. Le Clainche C, Carlier MF. 2008. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 88:489-513.
23. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clement M. 2001. ABH and Lewis histo-blood group antigens in cancer. APMIS 109:9-31.
24. Lee DH, Jung JY, Oh JH, Lee S, Kim YK, Chung JH. 2012. Ultraviolet irradiation modulates ABO blood group antigens in human skin in vivo: Possible implication in skin aging. J Dermatol Sci 66:71-73.
25. Lowe JB, Marth JD. 2003. A genetic approach to Mammalian glycan function. Annu Rev Biochem 72:643-691.
26. Luo BH, Springer TA, Takagi J. 2003. Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc Natl Acad Sci USA 100:2403-2408.
27. Margadant C, Charafeddine RA, Sonnenberg A. 2010. Unique and redundant functions of integrins in the epidermis. FASEB J 24:4133-4152.
28. Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoen N, Clement M, Le Pendu J. 2001. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83:565-573.
29. Mejias-Luque R, Lopez-Ferrer A, Garrido M, Fabra A, de Bolos C. 2007. Changes in the invasive and metastatic capacities of HT-29/M3 cells induced by the expression of fucosyltransferase 1. Cancer Sci 98:1000-1005.
30. Raja, Sivamani K, Garcia MS, Isseroff RR. 2007. Wound re-epithelialization: Modulating keratinocyte migration in wound healing. Front Biosci 12:2849-2868.
31. Ravn V, Dabelsteen E. 2000. Tissue distribution of histo-blood group antigens. APMIS 108:1-28.
32. Ridley AJ. 2006. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16:522-529.
33. Shiozaki K, Yamaguchi K, Takahashi K, Moriya S, Miyagi T. 2011. Regulation of sialyl Lewis antigen expression in colon cancer cells by sialidase NEU4. J Biol Chem 286:21052-21061.
34. Storry JR, Olsson ML. 2009. The ABO blood group system revisited: A review and update. Immunohematology 25:48-59.
35. Takahashi M, Kuroki Y, Ohtsubo K, Taniguchi N. 2009. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: Their functions and target proteins. Carbohydr Res 344:1387-1390.
36. Watkins WM. 1966. Blood-group substances. Science 152:172-181.
37. Werner S, Grose R. 2003. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-870.
38. Wood W, Martin P. 2002. Structures in focus-filopodia. Int J Biochem Cell Biol 34:726-730.
39. Xu M, Wang F, Gildersleeve JC, Achilefu S. 2010. MAb L9E10 to blood group H2 antigen binds to colon cancer stem cells and inhibits tumor cell migration and invasion. Hybridoma (Larchmt) 29:355-359.
40. Yamamoto F. 1995. Molecular genetics of the ABO histo-blood group system. Vox Sang 69:1-7.
41. Yamamoto F. 2004. Review: ABO blood group system-ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology 20:3-22.
42. Yan L, Lin B, Gao L, Gao S, Liu C, Wang C, Wang Y, Zhang S, Iwamori M. 2010. Lewis (y) Antigen Overexpression Increases the Expression of MMP-2 and MMP-9 and Invasion of Human Ovarian Cancer Cells. Int J Mol Sci 11:4441-4452.
43. Zhu K, Amin MA, Kim MJ, Katschke KJ, Jr., Park CC, Koch AE. 2003. A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1. J Biol Chem 278:21869-21877.
44. Zhu K, Amin MA, Zha Y, Harlow LA, Koch AE. 2005. Mechanism by which H-2g, a glucose analog of blood group H antigen, mediates angiogenesis. Blood 105:2343-2349.